<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>VitaminD3 | Health for you life</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="Vitamin D₃: Clinical Benefits, Deficiency Manifestations, and Practical Management

1. Introduction
Vitamin D is a fat‑soluble secosteroid hormone that exerts pleiotropic effects on bone metabolism, immune regulation, cellular proliferation, and cardiovascular homeostasis. Among its two major forms—vitamin D₂ (ergocalciferol) and vitamin D₃ (cholecalciferol)—the latter is the predominant circulating form in humans because it is synthesized endogenously in the skin upon exposure to ultraviolet B (UV‑B) radiation and is also obtained from animal‐derived foods. Clinical studies increasingly implicate adequate vitamin D₃ status as a cornerstone of public health, yet worldwide prevalence of deficiency remains high. This review delineates the mechanistic underpinnings of vitamin D₃ action, its proven therapeutic benefits, clinical sequelae when levels fall below optimal thresholds, and evidence‑based guidance for assessment and supplementation.">
    <meta name="generator" content="Hugo 0.148.2">
    
    
    
      <meta name="robots" content="index, follow">
    
    

    
<link rel="stylesheet" href="/ananke/css/main.min.8d048772ae72ab11245a0e296d1f2a36d3e3dd376c6c867394d6cc659c68fc37.css" >




    


    
      

    

    

    
      <link rel="canonical" href="https://a8king.com/post/VitaminD3.html">
    

    <meta property="og:url" content="https://a8king.com/post/VitaminD3.html">
  <meta property="og:site_name" content="Health for you life">
  <meta property="og:title" content="VitaminD3">
  <meta property="og:description" content="Vitamin D₃: Clinical Benefits, Deficiency Manifestations, and Practical Management
1. Introduction Vitamin D is a fat‑soluble secosteroid hormone that exerts pleiotropic effects on bone metabolism, immune regulation, cellular proliferation, and cardiovascular homeostasis. Among its two major forms—vitamin D₂ (ergocalciferol) and vitamin D₃ (cholecalciferol)—the latter is the predominant circulating form in humans because it is synthesized endogenously in the skin upon exposure to ultraviolet B (UV‑B) radiation and is also obtained from animal‐derived foods. Clinical studies increasingly implicate adequate vitamin D₃ status as a cornerstone of public health, yet worldwide prevalence of deficiency remains high. This review delineates the mechanistic underpinnings of vitamin D₃ action, its proven therapeutic benefits, clinical sequelae when levels fall below optimal thresholds, and evidence‑based guidance for assessment and supplementation.">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:modified_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:tag" content="Vitamin">

  <meta itemprop="name" content="VitaminD3">
  <meta itemprop="description" content="Vitamin D₃: Clinical Benefits, Deficiency Manifestations, and Practical Management
1. Introduction Vitamin D is a fat‑soluble secosteroid hormone that exerts pleiotropic effects on bone metabolism, immune regulation, cellular proliferation, and cardiovascular homeostasis. Among its two major forms—vitamin D₂ (ergocalciferol) and vitamin D₃ (cholecalciferol)—the latter is the predominant circulating form in humans because it is synthesized endogenously in the skin upon exposure to ultraviolet B (UV‑B) radiation and is also obtained from animal‐derived foods. Clinical studies increasingly implicate adequate vitamin D₃ status as a cornerstone of public health, yet worldwide prevalence of deficiency remains high. This review delineates the mechanistic underpinnings of vitamin D₃ action, its proven therapeutic benefits, clinical sequelae when levels fall below optimal thresholds, and evidence‑based guidance for assessment and supplementation.">
  <meta itemprop="datePublished" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="dateModified" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="wordCount" content="822">
  <meta itemprop="keywords" content="Vitamin">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="VitaminD3">
  <meta name="twitter:description" content="Vitamin D₃: Clinical Benefits, Deficiency Manifestations, and Practical Management
1. Introduction Vitamin D is a fat‑soluble secosteroid hormone that exerts pleiotropic effects on bone metabolism, immune regulation, cellular proliferation, and cardiovascular homeostasis. Among its two major forms—vitamin D₂ (ergocalciferol) and vitamin D₃ (cholecalciferol)—the latter is the predominant circulating form in humans because it is synthesized endogenously in the skin upon exposure to ultraviolet B (UV‑B) radiation and is also obtained from animal‐derived foods. Clinical studies increasingly implicate adequate vitamin D₃ status as a cornerstone of public health, yet worldwide prevalence of deficiency remains high. This review delineates the mechanistic underpinnings of vitamin D₃ action, its proven therapeutic benefits, clinical sequelae when levels fall below optimal thresholds, and evidence‑based guidance for assessment and supplementation.">

      
    
	
  </head><body class="ma0 avenir bg-near-white production">

    
   
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l center items-center justify-between">
    <a href="/" class="f3 fw2 hover-white white-90 dib no-underline">
      
        Health for you life
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/" title="Home page">
              Home
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/about/" title="About page">
              About
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/posts/" title="Posts page">
              Posts
            </a>
          </li>
          
        </ul>
      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l mw8 center ph3 flex-wrap justify-between">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref b helvetica tracked ttu">
          
        Posts
      </aside><div id="sharing" class="mt3 ananke-socials"><a href="mailto:?&amp;body=https%3A%2F%2Fa8king.com%2Fpost%2FVitaminD3.html&amp;subject=VitaminD3"
        class="ananke-social-link email no-underline"
        title="Share on Email" aria-label="Share on Email"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M64 112c-8.8 0-16 7.2-16 16l0 22.1L220.5 291.7c20.7 17 50.4 17 71.1 0L464 150.1l0-22.1c0-8.8-7.2-16-16-16L64 112zM48 212.2L48 384c0 8.8 7.2 16 16 16l384 0c8.8 0 16-7.2 16-16l0-171.8L322 328.8c-38.4 31.5-93.7 31.5-132 0L48 212.2zM0 128C0 92.7 28.7 64 64 64l384 0c35.3 0 64 28.7 64 64l0 256c0 35.3-28.7 64-64 64L64 448c-35.3 0-64-28.7-64-64L0 128z"/></svg>
                
              </span></a><a href="https://twitter.com/intent/tweet/?&amp;text=Vitamin%E2%80%AFD%E2%82%83%3A&#43;Clinical&#43;Benefits%2C&#43;Deficiency&#43;Manifestations%2C&#43;and&#43;Practical&#43;Management%0A1.&#43;Introduction&#43;Vitamin%E2%80%AFD&#43;is&#43;a&#43;fat%E2%80%91soluble&#43;secosteroid&#43;hormone&#43;that&#43;exerts&#43;pleiotropic&#43;effects&#43;on&#43;bone&#43;metabolism%2C&#43;immune&#43;regulation%2C&#43;cellular&#43;proliferation%2C&#43;and&#43;cardiovascular&#43;homeostasis.&#43;Among&#43;its&#43;two&#43;major&#43;forms%E2%80%94vitamin%E2%80%AFD%E2%82%82&#43;%28ergocalciferol%29&#43;and&#43;vitamin%E2%80%AFD%E2%82%83&#43;%28cholecalciferol%29%E2%80%94the&#43;latter&#43;is&#43;the&#43;predominant&#43;circulating&#43;form&#43;in&#43;humans&#43;because&#43;it&#43;is&#43;synthesized&#43;endogenously&#43;in&#43;the&#43;skin&#43;upon&#43;exposure&#43;to&#43;ultraviolet&#43;B&#43;%28UV%E2%80%91B%29&#43;radiation&#43;and&#43;is&#43;also&#43;obtained&#43;from&#43;animal%E2%80%90derived&#43;foods.&#43;Clinical&#43;studies&#43;increasingly&#43;implicate&#43;adequate&#43;vitamin%E2%80%AFD%E2%82%83&#43;status&#43;as&#43;a&#43;cornerstone&#43;of&#43;public&#43;health%2C&#43;yet&#43;worldwide&#43;prevalence&#43;of&#43;deficiency&#43;remains&#43;high.&#43;This&#43;review&#43;delineates&#43;the&#43;mechanistic&#43;underpinnings&#43;of&#43;vitamin%E2%80%AFD%E2%82%83&#43;action%2C&#43;its&#43;proven&#43;therapeutic&#43;benefits%2C&#43;clinical&#43;sequelae&#43;when&#43;levels&#43;fall&#43;below&#43;optimal&#43;thresholds%2C&#43;and&#43;evidence%E2%80%91based&#43;guidance&#43;for&#43;assessment&#43;and&#43;supplementation.%0A&amp;url=https%3A%2F%2Fa8king.com%2Fpost%2FVitaminD3.html"
        class="ananke-social-link twitter no-underline"
        title="Share on Twitter" aria-label="Share on Twitter"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg>
                
              </span></a></div>
<h1 class="f1 athelas mt3 mb1">VitaminD3</h1>
      
      
      
      <time class="f6 mv4 dib tracked" datetime="2025-08-20T00:00:00Z">August 20, 2025</time>
      

      
      
    </header>
    <div class="nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><p><strong>Vitamin D₃: Clinical Benefits, Deficiency Manifestations, and Practical Management</strong></p>
<hr>
<h3 id="1-introduction">1. Introduction</h3>
<p>Vitamin D is a fat‑soluble secosteroid hormone that exerts pleiotropic effects on bone metabolism, immune regulation, cellular proliferation, and cardiovascular homeostasis. Among its two major forms—vitamin D₂ (ergocalciferol) and vitamin D₃ (cholecalciferol)—the latter is the predominant circulating form in humans because it is synthesized endogenously in the skin upon exposure to ultraviolet B (UV‑B) radiation and is also obtained from animal‐derived foods. Clinical studies increasingly implicate adequate vitamin D₃ status as a cornerstone of public health, yet worldwide prevalence of deficiency remains high. This review delineates the mechanistic underpinnings of vitamin D₃ action, its proven therapeutic benefits, clinical sequelae when levels fall below optimal thresholds, and evidence‑based guidance for assessment and supplementation.</p>
<hr>
<h3 id="2-biosynthesis-and-metabolism">2. Biosynthesis and Metabolism</h3>
<table>
  <thead>
      <tr>
          <th>Step</th>
          <th>Location</th>
          <th>Enzymatic Conversion</th>
          <th>Key Modulators</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>1</strong></td>
          <td>Skin (keratinocytes)</td>
          <td>7‑dehydrocholesterol → previtamin D₃ (UV‑B, 290–315 nm)</td>
          <td>UV‑B dose, latitude, season, skin pigmentation, sunscreen use</td>
      </tr>
      <tr>
          <td><strong>2</strong></td>
          <td>Skin</td>
          <td>Previtamin D₃ → vitamin D₃ (thermal isomerization)</td>
          <td>Temperature, time of day</td>
      </tr>
      <tr>
          <td><strong>3</strong></td>
          <td>Liver (hepatocytes)</td>
          <td>Vitamin D₃ → 25‑hydroxyvitamin D₃ [25(OH)D] via CYP2R1, CYP27A1</td>
          <td>Hepatic function, genetic polymorphisms</td>
      </tr>
      <tr>
          <td><strong>4</strong></td>
          <td>Kidney (principal cells)</td>
          <td>25(OH)D → 1α,25‑dihydroxyvitamin D₃ [1α,25(OH)₂D] via CYP27B1</td>
          <td>PTH, calcium, phosphate, FGF23</td>
      </tr>
  </tbody>
</table>
<p><em>Catabolism:</em> 24‑hydroxylase (CYP24A1) degrades both 25(OH)D and 1α,25(OH)₂D to inactive metabolites, a process regulated by high vitamin D levels and low calcium.</p>
<hr>
<h3 id="3-clinical-benefits">3. Clinical Benefits</h3>
<h4 id="31-skeletal-health">3.1 Skeletal Health</h4>
<ul>
<li><strong>Calcium Homeostasis:</strong> 1α,25(OH)₂D upregulates intestinal calcium absorption via TRPV6 channels and calbindin-D9k expression.</li>
<li><strong>Bone Mineralization:</strong> Adequate vitamin D₃ prevents hypocalcemic secondary hyperparathyroidism, thereby reducing osteoclastic bone resorption. Randomized trials demonstrate that supplementation of 800–1 000 IU/day in adults ≥50 yr reduces fracture risk by ~10‑15 %.</li>
<li><strong>Osteomalacia &amp; Rickets:</strong> Severe deficiency leads to defective mineralization; radiographs show cupping, fraying of metaphyses.</li>
</ul>
<h4 id="32-immune-modulation">3.2 Immune Modulation</h4>
<ul>
<li><strong>Innate Immunity:</strong> Induction of antimicrobial peptides (cathelicidin LL‑37, defensins) enhances pathogen clearance in epithelial cells and macrophages.</li>
<li><strong>Adaptive Immunity:</strong> Vitamin D₃ skews T‑cell differentiation toward a regulatory phenotype (increased IL‑10, decreased IFN‑γ), dampening Th1/Th17 responses implicated in autoimmunity.</li>
</ul>
<h4 id="33-metabolic--cardiovascular-outcomes">3.3 Metabolic &amp; Cardiovascular Outcomes</h4>
<ul>
<li><strong>Insulin Secretion &amp; Sensitivity:</strong> Pancreatic β‑cells express VDR; vitamin D₃ improves insulin secretion and reduces insulin resistance in vitro. Meta‑analyses of cohort studies link serum 25(OH)D &gt;20 ng/mL to lower type‑2 diabetes incidence (HR ≈ 0.75).</li>
<li><strong>Hypertension &amp; Cardiac Remodeling:</strong> Vitamin D downregulates renin gene expression; deficiency correlates with elevated systolic BP and left ventricular hypertrophy on echocardiography.</li>
</ul>
<h4 id="34-oncologic-implications">3.4 Oncologic Implications</h4>
<ul>
<li><strong>Cellular Proliferation Control:</strong> VDR activation induces cyclin‑dependent kinase inhibitors (p21, p27) and promotes apoptosis in malignant cells. Epidemiologic evidence suggests inverse associations between vitamin D status and colorectal, breast, and prostate cancer risks.</li>
</ul>
<hr>
<h3 id="4-symptoms-and-clinical-consequences-of-deficiency">4. Symptoms and Clinical Consequences of Deficiency</h3>
<table>
  <thead>
      <tr>
          <th>System</th>
          <th>Early Manifestations</th>
          <th>Advanced / Chronic</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Musculoskeletal</strong></td>
          <td>Muscle aches, cramps, proximal myopathy</td>
          <td>Bone pain, fractures, osteomalacia</td>
      </tr>
      <tr>
          <td><strong>Neurologic</strong></td>
          <td>Fatigue, depression, cognitive decline</td>
          <td>Severe hypocalcemia → tetany, seizures</td>
      </tr>
      <tr>
          <td><strong>Immunologic</strong></td>
          <td>Recurrent infections (respiratory, GI)</td>
          <td>Autoimmune flares (multiple sclerosis, lupus)</td>
      </tr>
      <tr>
          <td><strong>Metabolic</strong></td>
          <td>Hyperparathyroidism signs: bone resorption, hyperphosphatemia</td>
          <td>Secondary osteoporosis, vascular calcification</td>
      </tr>
  </tbody>
</table>
<p><em>Diagnostic Clues:</em> Persistent low 25(OH)D (&lt;20 ng/mL), elevated PTH (&gt;65 pg/mL), hypocalcemia, and radiographic changes support deficiency diagnosis.</p>
<hr>
<h3 id="5-assessment-strategy">5. Assessment Strategy</h3>
<ol>
<li>
<p><strong>Risk Stratification</strong></p>
<ul>
<li>Age ≥65 yr, dark skin phenotype, limited sun exposure, obesity (volume sequestration), malabsorption syndromes, chronic kidney disease stages 3–4, medications affecting vitamin D metabolism (glucocorticoids, anticonvulsants).</li>
</ul>
</li>
<li>
<p><strong>Laboratory Testing</strong></p>
<ul>
<li><strong>Primary Test:</strong> Serum 25(OH)D via LC‑MS/MS or immunoassay (reference range: 30–100 ng/mL for optimal health).</li>
<li><strong>Supplementary Tests:</strong> Calcium, phosphate, PTH, creatinine, albumin.</li>
</ul>
</li>
<li>
<p><strong>Interpretation</strong></p>
<ul>
<li>Deficiency: &lt;20 ng/mL</li>
<li>Insufficiency: 21‑29 ng/mL</li>
<li>Sufficiency/Optimal: ≥30 ng/mL (up to 100 ng/mL; &gt;100 ng/mL may risk toxicity).</li>
</ul>
</li>
</ol>
<hr>
<h3 id="6-evidencebased-supplementation-guidelines">6. Evidence‑Based Supplementation Guidelines</h3>
<table>
  <thead>
      <tr>
          <th>Population</th>
          <th>Goal 25(OH)D Level</th>
          <th>Daily Dose</th>
          <th>Duration</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td>General adults</td>
          <td>≥30 ng/mL</td>
          <td>800–1 000 IU</td>
          <td>Continuous; reassess every 3–6 mo</td>
      </tr>
      <tr>
          <td>Older adults (≥65 yr), osteoporosis risk</td>
          <td>&gt;40 ng/mL</td>
          <td>1 200–2 000 IU</td>
          <td>Long‑term; monitor for hypercalcemia</td>
      </tr>
      <tr>
          <td>Deficient patients (&lt;20 ng/mL)</td>
          <td>≥30 ng/mL</td>
          <td><strong>Loading phase:</strong> 50 000 IU weekly × 6 wk (or 10 000 IU daily × 4 wk); then maintenance 800–1 000 IU/day</td>
          <td>Until target achieved, then maintenance</td>
      </tr>
      <tr>
          <td>Pregnant women</td>
          <td>&gt;30 ng/mL</td>
          <td>600 IU/day</td>
          <td>Throughout pregnancy</td>
      </tr>
      <tr>
          <td>Children (2–18 yr)</td>
          <td>≥30 ng/mL</td>
          <td>400–600 IU/day</td>
          <td>Continuous</td>
      </tr>
  </tbody>
</table>
<p><em>Safety Considerations:</em></p>
<ul>
<li><strong>Hypervitaminosis D</strong>: Symptoms include nausea, vomiting, polyuria, nephrolithiasis. Serum calcium &gt;10.5 mg/dL and 25(OH)D &gt;100 ng/mL are red flags.</li>
<li><strong>Drug Interactions:</strong> Rifampin, carbamazepine, phenytoin increase catabolism; higher doses may be required.</li>
</ul>
<hr>
<h3 id="7-lifestyle--dietary-recommendations">7. Lifestyle &amp; Dietary Recommendations</h3>
<table>
  <thead>
      <tr>
          <th>Modality</th>
          <th>Practical Tips</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Sun Exposure</strong></td>
          <td>10–30 min UV‑B exposure (arms, legs) mid‑morning/afternoon, 2–3×/week; avoid sunscreen during loading phase if safe.</td>
      </tr>
      <tr>
          <td><strong>Food Sources</strong></td>
          <td>Fatty fish (salmon, mackerel), cod liver oil, egg yolks, fortified dairy and plant milks, mushrooms exposed to UV light.</td>
      </tr>
      <tr>
          <td><strong>Weight Management</strong></td>
          <td>Obesity reduces bioavailability; weight loss improves circulating levels.</td>
      </tr>
      <tr>
          <td><strong>Renal Health</strong></td>
          <td>Monitor creatinine; adjust dose in CKD (e.g., 800 IU/day for stage 3).</td>
      </tr>
  </tbody>
</table>
<hr>
<h3 id="8-conclusion">8. Conclusion</h3>
<p>Vitamin D₃ occupies a central role in maintaining skeletal integrity, modulating immune responses, and influencing metabolic and cardiovascular health. The high prevalence of suboptimal status worldwide necessitates proactive screening, individualized supplementation, and vigilant monitoring to prevent deficiency‑related morbidity while avoiding toxicity. Future research should refine target thresholds for specific clinical populations and elucidate long‑term outcomes of sustained vitamin D₃ optimization.</p>
<hr>
<ul class="pa0">
  
   <li class="list di">
     <a href="/tags/vitamin/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">Vitamin</a>
   </li>
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




  <div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links">
    <p class="f5 b mb3">Related</p>
    <ul class="pa0 list">
	   
	     <li  class="mb2">
          <a href="/post/VitaminA.html">VitaminA</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminB12.html">VitaminB12</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminB3.html">VitaminB3</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminB5.html">VitaminB5</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminB7.html">VitaminB7</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminB9.html">VitaminB9</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminC.html">VitaminC</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminD.html">VitaminD</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminE.html">VitaminE</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/VitaminK.html">VitaminK</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B2.html">Vitamin_B2</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B6.html">Vitamin_B6</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/vitamin_b1.html">Vitamin_B1</a>
        </li>
	    
    </ul>
</div>

</aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white white-70 dn dib-ns pv2 ph3 no-underline" href="https://a8king.com/" >
    &copy;  Health for you life 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

  </body>
</html>
